James R. O’Dell

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 22 papers. Top paper: “Comparative Effectiveness of Allopurinol and Febuxostat in Gout Management”.

Comparative Effectiveness of Allopurinol and Febuxostat in Gout Management

NEJM Evidence(2022)10.1056/evidoa2100028

N/A

2.3DataRank · unranked

102 citations

Mary T. Brophy, Michael H. Pillinger, Tuhina Neogi, Paul M. Palevsky, Hongsheng Wu +12 more

Sustained xanthine oxidase inhibitor treat to target urate lowering therapy rewires a tight inflammation serum protein interactome

Research Square(2024)10.21203/rs.3.rs-3770277/v1

N/A

0.115DataRank · unranked

1 citations

Anamika Campeau, Ru Liu‐Bryan, Ted R. Mikuls, James R. O’Dell, David J. Gonzalez +2 more

Dexamethasone prodrug nanomedicine (ZSJ-0228) treatment significantly reduces lupus nephritis in mice without measurable side effects — A 5-month study

Nanomedicine Nanotechnology Biology and Medicine(2020)10.1016/j.nano.2020.102302

N/A

0DataRank · unranked

16 citations

Zhenshan Jia, Kirk Foster, Xin Wei, Fangfang Qiao, Haochen Jiang +9 more

Predictive ability, validity, and responsiveness of the multi-biomarker disease activity score in patients with rheumatoid arthritis initiating methotrexate

Seminars in Arthritis and Rheumatism(2020)10.1016/j.semarthrit.2020.05.019

N/A

0DataRank · unranked

12 citations

Tate Johnson, Harlan Sayles, Geoffrey M. Thiele, Ted R. Mikuls, James R. O’Dell +2 more

Head-to-head comparative pharmacokinetic and biodistribution (PK/BD) study of two dexamethasone prodrug nanomedicines on lupus-prone NZB/WF1 mice

Nanomedicine Nanotechnology Biology and Medicine(2020)10.1016/j.nano.2020.102266

N/A

0DataRank · unranked

9 citations

Gang Zhao, Xiaobei Wang, Nagsen Gautam, Zhenshan Jia, Zhifeng Zhao +14 more

Associations of joint swelling, joint stiffness, and joint pain with physical activity in first-degree relatives of patients with rheumatoid arthritis

medRxiv(2020)10.1101/2020.06.13.20130526

N/A

0DataRank · unranked

1 citations

Joachim H. Ix, Samuel R. Ward, Michael H. Weisman, James R. O’Dell, Ted R. Mikuls +8 more

Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity

PLoS ONE(2021)10.1371/journal.pone.0244187

N/A

0DataRank · unranked

32 citations

Rachael E. Hawtin, Dongmei Sun, Brent Louie, Erik Evensen, Barbara B. Mittleman +28 more

Plasma Metabolome Normalization in Rheumatoid Arthritis Following Initiation of Methotrexate and the Identification of Metabolic Biomarkers of Efficacy

Metabolites(2021)10.3390/metabo11120824

N/A

0DataRank · unranked

23 citations

Pooja Bhadbhade, Ted R. Mikuls, James R. O’Dell, Rebekah L. Gundry, Ryan S. Funk +1 more

Evaluating associations of joint swelling, joint stiffness and joint pain with physical activity in first-degree relatives of patients with rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA), a prospective cohort study

BMJ Open(2021)10.1136/bmjopen-2021-050883

N/A

0DataRank · unranked

6 citations

Joachim H. Ix, Samuel R. Ward, Michael H. Weisman, James R. O’Dell, Ted R. Mikuls +8 more

Association of Antibodies to Prevotella copri in Anti–Cyclic Citrullinated Peptide‐Positive Individuals At Risk of Developing Rheumatoid Arthritis and in Patients With Early or Established Rheumatoid Arthritis

Arthritis & Rheumatology(2022)10.1002/art.42370

N/A

0DataRank · unranked

36 citations

Elizabeth A. Bemis, Kristina Ramsden, Cassidy Lowell, Kristen J. Polinski, Marie L. Feser +13 more

Plasma metabolomic profiling as a tool to identify predictive biomarkers of methotrexate efficacy in rheumatoid arthritis

Seminars in Arthritis and Rheumatism(2022)10.1016/j.semarthrit.2022.152056

N/A

0DataRank · unranked

14 citations

Leonidas E. Bantis, Peng Shi, Pooja Bhadbhade, Rebekah L. Gundry, Ted R. Mikuls +4 more

Relationship Between a Vitamin D Genetic Risk Score and Autoantibodies Among First-Degree Relatives of Probands With Rheumatoid Arthritis and Systemic Lupus Erythematosus

Frontiers in Immunology(2022)10.3389/fimmu.2022.881332

N/A

0DataRank · unranked

11 citations

Elizabeth A. Bemis, Jennifer Seifert, Joel M. Guthridge, Kendra A. Young, M. Kristen Demoruelle +16 more

Cause‐Specific Mortality in Patients With Gout in the US Veterans Health Administration: A Matched Cohort Study

Arthritis Care & Research(2022)10.1002/acr.24881

N/A

0DataRank · unranked

10 citations

Bryant R. England, Punyasha Roul, Harlan Sayles, Alison Petro, Tuhina Neogi +3 more

Determinants of Achieving Serum Urate Goal with Treat‐to‐Target Urate‐Lowering Therapy in Gout

Arthritis & Rheumatology(2023)10.1002/art.42731

N/A

0DataRank · unranked

21 citations

James R. O’Dell, Jeff A. Newcomb, Maria Androsenko, Mary T. Brophy, Anne Davis‐Karim +9 more

Comparison of Gout Flares With the Initiation of Treat‐to‐Target Allopurinol and Febuxostat: A Post‐Hoc Analysis of a Randomized Multicenter Trial

Arthritis & Rheumatology(2024)10.1002/art.42927

N/A

0DataRank · unranked

10 citations

Lindsay N. Helget, Maria Androsenko, Hongsheng Wu, Bridget Kramer, Jeff A. Newcomb +11 more

Effective xanthine oxidase inhibitor urate lowering therapy in gout is linked to an emergent serum protein interactome of complement activation and inflammation modulators

Research Square(2024)10.21203/rs.3.rs-4278877/v1

N/A

0DataRank · unranked

0 citations

Anaamika Campeau, Ru Liu‐Bryan, Ted R. Mikuls, James R. O’Dell, David J. Gonzalez +2 more

A Phase 2 Trial of Hydroxychloroquine in Individuals at Risk for Rheumatoid Arthritis

Arthritis & Rheumatology(2025)10.1002/art.43366

N/A

0DataRank · unranked

16 citations

Christopher C. Striebich, Marie L. Feser, James R. O’Dell, Judith A. James, Jeffrey A. Sparks +29 more

Improvements in Health‐Related Quality of Life With Treat‐to‐Target Urate‐Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial

Arthritis Care & Research(2025)10.1002/acr.25618

N/A

0DataRank · unranked

3 citations

Bryant R. England, Harlan Sayles, Lindsay N. Helget, Maria Androsenko, Hongsheng Wu +12 more

Real-world persistence of urate-lowering therapy following a treat-to-target intervention: A two-year follow-up analysis of the STOP gout trial

Seminars in Arthritis and Rheumatism(2025)10.1016/j.semarthrit.2025.152800

N/A

0DataRank · unranked

1 citations

Harlan Sayles, Lindsay N. Helget, Bryant R. England, Punyasha Roul, Jeff A. Newcomb +11 more

Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF

Arthritis Research & Therapy(2020)10.1186/s13075-020-02198-9

N/A

0DataRank · unranked

20 citations

In Ah Choi, Françoise Meylan, M. Kristen Demoruelle, Taylor K. Farley, Arianne C. Richard +24 more

Long‐Term Opioids in Gout: A Matched Cohort Study From the Veterans Health Administration

Arthritis Care & Research(2025)10.1002/acr.25622

N/A

0DataRank · unranked

0 citations

Bryant R. England, Punyasha Roul, Harlan Sayles, Tuhina Neogi, James R. O’Dell +3 more

Association of Lipid Mediators With Development of Future Incident Inflammatory Arthritis in an Anti–Citrullinated Protein Antibody–Positive Population

Arthritis & Rheumatology(2020)10.1002/art.41631

N/A

0DataRank · unranked

21 citations

Elizabeth A. Bemis, Fan Yang, Tessa Crume, M. Kristen Demoruelle, Marie L. Feser +13 more